Pharma ESG report – March 2021 – May 2021

With the current drive to supply the world with vaccines, there is much greater interest and visibility on pharma firms’ product quality and safety than ever before. J&J (-39) and AstraZeneca’s (-25) scores decline from the previous quarter as both their COVID-19 vaccines are linked with blood clots.

Top performer Sanofi (+68) improves dramatically as it creates a non-profit unit to provide the poorest countries with access to essential medicines. Biogen (+63) receives the biggest quarter-on-quarter shift due to employee engagement and health & safety initiatives.

Download the full report here.